Tempus AI Common Stock Net 2023-2025 | TEM

Tempus AI common stock net from 2023 to 2025. Common stock net can be defined as the value of common equity ownership.
  • Tempus AI common stock net for the quarter ending March 31, 2025 was $0.000B, a 200% increase year-over-year.
  • Tempus AI common stock net for 2024 was $0B, a 183.33% increase from 2023.
  • Tempus AI common stock net for 2023 was $0B, a 0% decline from 2022.
  • Tempus AI common stock net for 2022 was $0B, a 0% decline from .
Tempus AI Annual Common Stock Net
(Millions of US $)
2024 $0
2023 $0
2022 $0
Tempus AI Quarterly Common Stock Net
(Millions of US $)
2025-03-31 $0
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31 $0
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $9.996B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.994B 58.52
Hims & Hers Health (HIMS) United States $12.427B 102.82
Doximity (DOCS) United States $10.881B 50.37
IRhythm Technologies (IRTC) United States $5.151B 0.00
Hinge Health (HNGE) United States $3.762B 0.00
Inspire Medical Systems (INSP) United States $2.600B 38.22
Privia Health (PRVA) United States $2.371B 162.08
10x Genomics (TXG) United States $1.639B 0.00
Phreesia (PHR) United States $1.613B 0.00
Enovis (ENOV) United States $1.511B 8.43
Clover Health Investments (CLOV) United States $1.450B 0.00
Schrodinger (SDGR) United States $1.441B 0.00
Omnicell (OMCL) United States $1.429B 26.99
Azenta (AZTA) United States $1.231B 53.80
Evolent Health (EVH) United States $1.115B 95.00
Claritev (CTEV) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.636B 0.00
Veradigm (MDRX) United States $0.514B 0.00
Standard BioTools (LAB) United States $0.494B 0.00
Talkspace (TALK) United States $0.380B 113.50
Zepp Health (ZEPP) Netherlands $0.349B 0.00
Butterfly Network (BFLY) United States $0.336B 0.00
Carlsmed (CARL) $0.325B 0.00
TruBridge (TBRG) United States $0.314B 696.33
Health Catalyst (HCAT) United States $0.266B 0.00
Nyxoah SA (NYXH) Belgium $0.254B 0.00
Outset Medical (OM) United States $0.250B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.228B 0.00
CapsoVision (CV) United States $0.192B 0.00
KORU Medical Systems (KRMD) United States $0.151B 0.00
American Well (AMWL) United States $0.132B 0.00
MDxHealth SA (MDXH) Belgium $0.118B 0.00
EUDA Health Holdings (EUDA) Singapore $0.113B 0.00
CareCloud (CCLD) United States $0.101B 4.58
ImmunoPrecise Antibodies (IPA) Canada $0.084B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.075B 0.00
Pulmonx (LUNG) United States $0.067B 0.00
111 (YI) China $0.059B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
HeartBeam (BEAT) United States $0.034B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00